Company Overview of Dance BioPharm Inc.
Dance Biopharm Inc., a development stage biopharmaceutical company, focuses on the development of inhaled insulin products for the treatment of diabetes worldwide. Its lead product candidate includes Dance 501, a drug/device combination product to deliver a high purity liquid insulin formulation through a small handheld electronic inhaler that has completed Phase II clinical trials in adult patients with type 2 diabetes. The company was formerly known as Dance Pharmaceuticals, Inc. and changed its name to Dance Biopharm Inc. in February 2013. Dance Biopharm Inc. was founded in 2009 and is based in Brisbane, California.
150 North Hill Drive
Brisbane, CA 94005
Founded in 2009
Key Executives for Dance BioPharm Inc.
Dance BioPharm Inc. Key Developments
Similar Private Companies By Industry
|Pel-Freez Arkansas, LLC||United States|
|Hemodyne, Inc.||United States|
|Restoragen Inc.||United States|
|Talon Therapeutics, Inc.||United States|
|LipoScience, Inc.||United States|
Recent Private Companies Transactions
December 19, 2014
To contact Dance BioPharm Inc., please visit www.dancebiopharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.